Showing 481 - 500 results of 1,866 for search '"spondylitis"', query time: 0.10s Refine Results
  1. 481

    circIFNGR2 regulating ankylosing spondylitis-associated inflammation through macrophage polarization by Minkai Song, Xiangyu Wang, Jiawen Gao, Weizhou Jiang, Enguang Bi, Taixue An, Ting Wang, Zishuo Chen, Weilu Liu, Zhanjun Shi, Jun Xiao, Chao Zhang

    Published 2023-08-01
    “…Summary: Macrophages activation is crucial in pathogenesis of rheumatic diseases like ankylosing spondylitis (AS). Circular RNAs (circRNAs)-induced macrophage-associated inflammation participates in many autoimmune diseases but remains elusive in AS. …”
    Get full text
    Article
  2. 482
  3. 483
  4. 484
  5. 485
  6. 486
  7. 487

    CO-MORBIDITY AND FORECASTING THE RISK OF POST-OPERATIVE INFECTIOUS COMPLICATIONS IN TUBERCULOUS SPONDYLITIS PATIENTS by S. V. Burlakov, A. A. Vishnevskiy

    Published 2016-11-01
    “…Surgical treatment of 41 patients with infectious spondylitis was retrospectively analyzed. Patients were divided into 2 groups. …”
    Get full text
    Article
  8. 488
  9. 489
  10. 490
  11. 491
  12. 492
  13. 493
  14. 494

    Evaluation of Human Leukocyte Antigen-B27 Expression in Patients with Spondylopathy/Spondylitis by Flowcytometry by Deepali Saxena, Pankaj Arora, Seema Acharya, Sana Ahuja

    Published 2023-04-01
    “…Introduction: The role of immune mediated injury in pathogenesis of Ankylosing Spondylitis (AS) is well established. HLA B27, a Major Histocompatibility Complex (MHC) class I molecule is one of the major genetic risk factors associated with the disease. …”
    Get full text
    Article
  15. 495
  16. 496

    Comprehensive treatment of tuberculous spondylitis with short course pre-operative anti-tuberculosis therapy by G. G. Golkа, V. V. Vesnin, V. V. Burlаkа, O. G. Fаdeev, A. A. Oleynik

    Published 2021-04-01
    “…The objective: to increase the effectiveness of treatment of patients with tuberculous spondylitis by using short course pre-operative anti-tuberculosis therapy.Subjects and methods. …”
    Get full text
    Article
  17. 497
  18. 498

    A review of 100 patients with ankylosing spondylitis with particular reference to socio-economic effects. by Wordsworth, B, Mowat, A

    Published 1986
    “…One hundred patients with ankylosing spondylitis of at least 5 years' duration were interviewed and examined. …”
    Journal article
  19. 499

    Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases by Hammitzsch, A, Chen, L, de Wit, J, Al-Mossawi, H, Ridley, A, Sekine, T, Simone, D, Doig, K, Skapenko, A, Bowness, P

    Published 2018
    “…Treatment options for Ankylosing Spondylitis (AS) are still limited. The T helper cell 17 (Th17) pathway has emerged as a major driver of disease pathogenesis and a good treatment target. …”
    Journal article
  20. 500